Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Corrado Pelaia, Anna Ferrante Bannera, Fioramante Lello Rotundo, Francesco Giuseppe Tropea, Giuseppe Armentaro, Angelantonio Maglio, Angela Sciacqua, Alessandro Vatrella & Girolamo Pelaia. (2023) Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 995-1002.
Read now
Read now
Arschang Valipour, Sergey Avdeev, Adam Barczyk, Valentina Bayer, Zvi Fridlender, Mariela Georgieva, Ondřej Kudela, Alexey Medvedchikov, Ramona Miron, Maria Sanzharovskaya, Virginija Šileikienė, Jurij Šorli, Marc Spielmanns & Zsuzsanna Szalai. (2021) Therapeutic Success of Tiotropium/Olodaterol, Measured Using the Clinical COPD Questionnaire (CCQ), in Routine Clinical Practice: A Multinational Non-Interventional Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 615-628.
Read now
Read now
Anthony D. D’Urzo, Dave Singh, James F. Donohue, Kenneth R. Chapman & Robert A. Wise. (2021) Aclidinium bromide/formoterol fumarate as a treatment for COPD: an update. Expert Review of Respiratory Medicine 15:9, pages 1093-1106.
Read now
Read now
Chad Moretz, Ashley L Cole, George Mu, Benjamin Wu, Amy Guisinger, Yunhao Liu, Beth Hahn & Lee Baylis. (2020) Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2207-2215.
Read now
Read now
Ryan Haley, Nita Gupta & Sanjay Sethi. (2020) Aclidinium bromide and formoterol fumarate for the maintenance treatment of chronic obstructive pulmonary disease. Expert Review of Clinical Pharmacology 13:2, pages 103-113.
Read now
Read now
Arschang Valipour, Michael Tamm, Jana Kociánová, Valentina Bayer, Maria Sanzharovskaya, Alexey Medvedchikov, Monika Haaksma-Herczegh, János Mucsi, Zvi Fridlender, Claudia Toma, Andrey Belevskiy, Bohumil Matula & Jurij Šorli. (2019) Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2343-2354.
Read now
Read now
Articles from other publishers (25)
Prahlad Prabhudesai, Bhanu P Singh, Gyanendra Agrawal, Ashok Kumar Singh, Amit Y Jadhav, Saurabh R Patil, Sagar Bhagat, Saiprasad Patil & Hanmant Barkate. (2023) Fluticasone Furoate/Vilanterol Use Trends and Characteristics in Patients With Obstructive Airway Disease: A Real-World Study of 10,374 Patients From India. Cureus.
Crossref
Crossref
Marc Miravitlles, Tomotaka Kawayama & Michael Dreher. (2022) LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations. Journal of Clinical Medicine 11:22, pages 6623.
Crossref
Crossref
Raja Dhar, Deepak Talwar, Prince James, Ashwini Mishra, Judo Vachaparambil, Saiprasad Patil, Nishtha Khatri, Sagar Bhagat & Hanmant Barkate. (2022) ICS/Ultra LABA in the Treatment of Obstructive Airway Diseases: A Consensus of Indian Experts. Advances in Respiratory Medicine 90:5, pages 407-424.
Crossref
Crossref
Mario Cazzola, Clive Page, Paola Rogliani, Luigino Calzetta & Maria Gabriella Matera. (2022) Dual bronchodilation for the treatment of COPD: From bench to bedside. British Journal of Clinical Pharmacology 88:8, pages 3657-3673.
Crossref
Crossref
Brit Long & Salim R. Rezaie. (2022) Evaluation and Management of Asthma and Chronic Obstructive Pulmonary Disease Exacerbation in the Emergency Department. Emergency Medicine Clinics of North America 40:3, pages 539-563.
Crossref
Crossref
Sundeep Salvi, ManishK Jain, Srikanth Krishnamurthy, Akash Balki, Rahul Kodgule, Monika Tandon, Sagar Bhagat, Sagar Panchal, Nishtha Khatri, Wen Wu, Amol Pendse, Saiprasad Patil & Hanmant Barkate. (2022) Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to–severe COPD. Lung India 39:6, pages 517.
Crossref
Crossref
Hanna Sandelowsky, Ulla Møller Weinreich, Bernt B. Aarli, Josefin Sundh, Kristian Høines, Georgios Stratelis, Anders Løkke, Christer Janson, Christian Jensen & Kjell Larsson. (2021) COPD – do the right thing. BMC Family Practice 22:1.
Crossref
Crossref
Masato Muraki, Yuki Kunita, Ken Shirahase, Ryo Yamazaki, Soichiro Hanada, Hirochiyo Sawaguchi & Yuji Tohda. (2021) A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Bruno Sposato, Elisa Petrucci, Andrea Serafini, Fabio Lena, Leonardo Gianluca Lacerenza, Andrea Montagnani, Massimo Alessandri, Alberto Cresti, Raffaele Scala, Paola Rogliani, Alberto Ricci, Antonio Perrella & Marco Scalese. (2021) Which LABA/LAMA should be chosen in COPD patients in real life?. Pulmonary Pharmacology & Therapeutics 71, pages 102076.
Crossref
Crossref
Dong-Wook Kim & Kwon Yeon Weon. (2021) Pharmaceutical application and development of fixed-dose combination: dosage form review. Journal of Pharmaceutical Investigation 51:5, pages 555-570.
Crossref
Crossref
Sally Spencer, Oliver Hamer, Elizabeth Berger, Andrew Booth, Greg J Irving, Michael Owen, Nicola Relph, Omar Usmani & Carol Kelly. (2021) Interventions to improve inhaler technique for adults with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2021:7.
Crossref
Crossref
Mario Cazzola, Maria Gabriella Matera, Paola Rogliani & Luigino Calzetta. (2021) Comparative studies of dual bronchodilation in COPD. Monaldi Archives for Chest Disease 91:1.
Crossref
Crossref
François Maltais, Alberto de la Hoz, Richard Casaburi & Denis O’Donnell. (2020) Effects of Tiotropium/Olodaterol on Activity-Related Breathlessness, Exercise Endurance and Physical Activity in Patients with COPD: Narrative Review with Meta-/Pooled Analyses. Advances in Therapy 38:2, pages 835-853.
Crossref
Crossref
Joseph O. Fadare, Abimbola Margaret Obimakinde, Felix O. Aina, Ebisola J. Araromi, Theophilus Adekunle Adegbuyi, Oluwatoba E. Osasona & Tosin A. Agbesanwa. (2021) Anti-Cholinergic Drug Burden Among Ambulatory Elderly Patients in a Nigerian Tertiary Healthcare Facility. Frontiers in Pharmacology 12.
Crossref
Crossref
Yinghan Chan, Sin Wi Ng, Hui Shan Liew, Lesley Jia Wei Pua, Laura Soon, Jun Sing Lim, Kamal Dua & Dinesh Kumar Chellappan. 2021. Medicinal Plants for Lung Diseases. Medicinal Plants for Lung Diseases
47
84
.
Jinping Zheng, Jin-fu Xu, Martin Jenkins, Pryseley Nkouibert Assam, Lijiao Wang & Brian J. Lipworth. (2020) Glycopyrrolate/formoterol fumarate metered dose inhaler for maintenance-naïve patients with chronic obstructive pulmonary disease: a post-hoc analysis of the randomized PINNACLE trials. Respiratory Research 21:1.
Crossref
Crossref
Mauro Carone, Alfio Pennisi, Mariella D’Amato, Alfeo Fiore Donati, Alberto Ricci, Carla Scognamillo, Li Chun, Maria Aliani, Valeria Ronsivalle & Girolamo Pelaia. (2020) Physical Functioning in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium/Olodaterol Respimat in Routine Clinical Practice in Italy. Pulmonary Therapy 6:2, pages 261-274.
Crossref
Crossref
Randy Sorge & Peter DeBlieux. (2020) Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Primer for Emergency Physicians. The Journal of Emergency Medicine 59:5, pages 643-659.
Crossref
Crossref
S N Avdeev, Z R Aisanov, A S Belevsky, K M Beeh, A A Vizel, S K Zyryanov, G L Ignatova, K Kostikas, I V Leshchenko, S I Ovcharenko, A I Sinopal’nikov, O N Titova & E I Shmelev. (2020) The concept of chronic obstructive pulmonary disease clinical control as a decision - making tool in real clinical practice for optimizing of basic pharmacotherapy. Terapevticheskii arkhiv 92:1, pages 89-95.
Crossref
Crossref
Jian Kang, Jinping Zheng, Baiqiang Cai, Fuqiang Wen, Wanzhen Yao, Xiaoju Zhang, Yan Chen, Guansong Wang, Wen Li & Jie Cao. (2020) Current situation of asthma–COPD overlap in Chinese patients older than 40 years with airflow limitation: a multicenter, cross-sectional, non-interventional study. Therapeutic Advances in Respiratory Disease 14, pages 175346662096169.
Crossref
Crossref
Ching-Yi Chen, Wang-Chun Chen, Chi-Hsien Huang, Yi-Ping Hsiang, Chau-Chyun Sheu, Yung-Che Chen, Meng-Chih Lin, Kuo-An Chu, Cheng-Hung Lee & Yu-Feng Wei. (2020)
LABA/LAMA fixed-dose combinations
versus
LAMA monotherapy in the prevention of COPD exacerbations: a systematic review and meta-analysis
. Therapeutic Advances in Respiratory Disease 14, pages 175346662093719.
Crossref
Crossref
M. G. Matera, C. P. Page, L. Calzetta, P. Rogliani & M. Cazzola. (2019) Pharmacology and Therapeutics of Bronchodilators Revisited. Pharmacological Reviews 72:1, pages 218-252.
Crossref
Crossref
Hannah R. Whittaker, Debbie Jarvis, Mohamed R. Sheikh, Steven J. Kiddle & Jennifer K. Quint. (2019) Inhaled corticosteroids and FEV1 decline in chronic obstructive pulmonary disease: a systematic review. Respiratory Research 20:1.
Crossref
Crossref
Eric Derom, Guy G. Brusselle & Guy F. Joos. (2019) The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects. Therapeutic Advances in Respiratory Disease 13, pages 175346661984342.
Crossref
Crossref
Eneida M. Harrison & Victor Kim. (2019) Long-acting maintenance pharmacotherapy in chronic obstructive pulmonary disease. Respiratory Medicine: X 1, pages 100009.
Crossref
Crossref